Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Frontiers in Pharmacology|April 1, 2020
Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase InhibitorsMaddalena Centanni, Lena E FribergClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2020
Model-based Dose Individualization of Sunitinib in Gastrointestinal Stromal TumorsMaddalena Centanni, Sreenath M Krishnan, Lena E FribergPharmacoeconomics|September 10, 2025
Eco Friendly and Budget Smart: An Economic and Environmental Evaluation of Alternative PD-1 and PD-L1 Inhibitor Dosing RegimensLeo Karlsson, Joseph Ciccolini, Rob Ter Heine, et al.Pharmacoeconomics|September 26, 2024
Comparative Analysis of Traditional and Pharmacometric-Based Pharmacoeconomic Modeling in the Cost-Utility Evaluation of Sunitinib TherapyMaddalena Centanni, Janine Nijhuis, Mats O Karlsson, et al.Journal of Clinical Pharmacology|January 25, 2019
Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to HumanYin Cheong Wong, Maddalena Centanni, Elizabeth C M de LangeClinical and Translational Science|September 24, 2022
Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine-kinase inhibitorsMaddalena Centanni, Abel Thijs, Ingrid Desar, et al.Clinical Pharmacokinetics|June 6, 2024
Pharmacogenetic Testing or Therapeutic Drug Monitoring: A Quantitative FrameworkMaddalena Centanni, Niels Reijnhout, Abel Thijs, et al.Cancer Chemotherapy and Pharmacology|May 23, 2024
Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to childrenMaddalena Centanni, Omar Zaher, David Elhad, et al.Advanced Drug Delivery Reviews|November 22, 2024
Integrated modeling of biomarkers, survival and safety in clinical oncology drug developmentHan Liu, Eman I K Ibrahim, Maddalena Centanni, et al.Clinical Pharmacokinetics|March 1, 2019
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint InhibitorsMaddalena Centanni, Dirk Jan A R Moes, Iñaki F Trocóniz, et al.Pageof 2